The microcosmos of intratumor heterogeneity: the space-time of cancer evolution.

Abstract:

:The Cancer Genome Atlas consortium brought us terabytes of information about genetic alterations in different types of human tumors. While many cancer-driver genes have been identified through these efforts, interrogating cancer genomes has also shed new light on tumor complexity. Mutations were found to vary tremendously in their allelic frequencies within the same tumor. Based on those variant allelic frequencies grouping, an estimate of genetically distinct "clones" of cancer cells can be determined for each tumor. It was estimated that 4-8 clones are present in every human tumor. Presence of distinct clones, cells that differ in their genotype and/or phenotype, is one of the roots for the major challenge of effectively curing cancer patients. Any given treatment applied to a heterogeneous mixture of cancer cells will yield distinct responses in different cells and may be ineffective in killing particular clones. Moreover, in highly heterogeneous tumors, stochastically, there is a higher chance of presence of traits, such as point mutations in key receptor tyrosine kinases, that drive drug resistance. Thus, intratumor heterogeneity is like an arsenal, providing a variety of weapons for self-defense against cancer-targeted therapy. However, in this arsenal the supplies are constantly changing, as cancer cells are accumulating new mutations. What is also changing is the battlefield-the tumor microenvironment including all noncancerous cells within the tumor and surrounding tissue, which also contribute to the diversification of cancer's forces. In order to design more effective therapies that would target this ever-changing landscape, we need to learn more about the two elusive variables that shape the tumor ecosystem: the space-how could we exploit the organization of tumor microenvironment? and the time-how could we predict the changes in heterogeneous tumors?

journal_name

Oncogene

journal_title

Oncogene

authors

Janiszewska M

doi

10.1038/s41388-019-1127-5

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

2031-2039

issue

10

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-019-1127-5

journal_volume

39

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

    abstract::We have recently described the N-terminal RAS association domain family of genes, RASSF7-10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5'-CpG island in acute lymphoblastic leukemia. To characterize RASSF10 gene expression, we demonstrate that in developin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.471

    authors: Hill VK,Underhill-Day N,Krex D,Robel K,Sangan CB,Summersgill HR,Morris M,Gentle D,Chalmers AD,Maher ER,Latif F

    更新日期:2011-02-24 00:00:00

  • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

    abstract::Constitutive activation of signal transducer and activator of transcription (STAT) proteins has been detected in a wide variety of human primary tumor specimens and tumor cell lines including blood malignancies, head and neck cancer, and breast cancer. We have previously demonstrated a high frequency of Stat3 DNA-bind...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204349

    authors: Garcia R,Bowman TL,Niu G,Yu H,Minton S,Muro-Cacho CA,Cox CE,Falcone R,Fairclough R,Parsons S,Laudano A,Gazit A,Levitzki A,Kraker A,Jove R

    更新日期:2001-05-03 00:00:00

  • Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.

    abstract::Rhabdomyosarcoma (RMS) tumors are the most common soft-tissue sarcomas in childhood. In this investigation, we show that myostatin, a skeletal muscle-specific inhibitor of growth and differentiation is expressed and translated in the cultured RMS cell line, RD. The addition of exogenous recombinant myostatin inhibits ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207144

    authors: Langley B,Thomas M,McFarlane C,Gilmour S,Sharma M,Kambadur R

    更新日期:2004-01-15 00:00:00

  • Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.

    abstract::Constitutive expression of the activated Rap1A protein inhibits differentiation of myogenic C2 cells whereas the inactivated Rap1A protein favours cell differentiation and induces late endocytic compartments clustering. Although the role of Rap1A in MAPK activation has been analysed in various cell types, the signalli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203984

    authors: Pizon V,Baldacci G

    更新日期:2000-12-07 00:00:00

  • DNA methylation and gene silencing in cancer: which is the guilty party?

    abstract::The DNA methylation pattern of a cell is exquisitely controlled during early development resulting in distinct methylation patterns. The tight control of DNA methylation is released in the cancer cell characterized by a reversal of methylation states. CpG island associated genes, in particular tumour suppressor or rel...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205598

    authors: Clark SJ,Melki J

    更新日期:2002-08-12 00:00:00

  • Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene.

    abstract::We have isolated a candidate tumor suppressor gene from a 600-kb region on chromosome 8p21.3-p22 that is commonly deleted in sporadic hepatocellular carcinomas (HCC), colorectal cancers (CRC), and non-small cell lung cancers (NSCLC). As this gene encodes a protein of 375 amino acids that bears significant sequence sim...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Fujiwara Y,Ohata H,Kuroki T,Koyama K,Tsuchiya E,Monden M,Nakamura Y

    更新日期:1995-03-02 00:00:00

  • Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells.

    abstract::The differentiation of primary myogenic cultures requires the attachment of the cells to an extracellular matrix substrate using an integrin family receptor. These integrin receptors can be phosphorylated on both their alpha and beta chains, and it has been postulated that phosphorylation regulates the receptor functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Aneskievich BJ,Haimovich B,Boettiger D

    更新日期:1991-08-01 00:00:00

  • An RNF11: Smurf2 complex mediates ubiquitination of the AMSH protein.

    abstract::RING-finger proteins play crucial roles in ubiquitination events involved in diverse cellular processes including signal transduction, differentiation and apoptosis. Most of the RING-finger proteins have E3-ubiquitin ligase activity. RNF11 is a small RING-finger protein and harbors a RING-H2 domain and a PY motif that...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207319

    authors: Li H,Seth A

    更新日期:2004-03-11 00:00:00

  • Molecular characterization and modular analysis of human MyD88.

    abstract::MyD88 was first characterized as a myeloid differentiation primary response gene in mice, activated in M1 myeloleukemic cells following interleukin-6 (IL-6) induced growth arrest and terminal differentiation. Analysis of expressed sequence tags (ESTs) from activated dendritic cell libraries led to the indentification ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hardiman G,Rock FL,Balasubramanian S,Kastelein RA,Bazan JF

    更新日期:1996-12-05 00:00:00

  • The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.

    abstract::The E6 proteins of specific cancer-associated human papillomaviruses (HPVs) complex with and mediate degradation of the cellular anti-oncogene p53 in vitro. A critical property of p53 is its ability to stimulate transcription from promoters containing its recognition sequence. HPV E6, mutant p53 proteins, and several ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mansur CP,Marcus B,Dalal S,Androphy EJ

    更新日期:1995-02-02 00:00:00

  • TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.

    abstract::The chromatin state is finely tuned to regulate function and specificity for transcription factors such as oestrogen receptor alpha (ER), which contributes to cell growth in breast cancer. ER transcriptional potential is mediated, in large part, by the specific associated proteins and co-factors that interact with it....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0312-2

    authors: Serandour AA,Mohammed H,Miremadi A,Mulder KW,Carroll JS

    更新日期:2018-09-01 00:00:00

  • Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis.

    abstract::Mitochondrial membrane permeabilization is a critical event in the process leading to physiological or chemotherapy-induced apoptosis. This permeabilization event is at least in part under the control of the permeability transition pore complex (PTPC), which interacts with oncoproteins from the Bcl-2 family as well as...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203299

    authors: Costantini P,Belzacq AS,Vieira HL,Larochette N,de Pablo MA,Zamzami N,Susin SA,Brenner C,Kroemer G

    更新日期:2000-01-13 00:00:00

  • Viral rel and cellular rel associate with cellular proteins in transformed and normal cells.

    abstract::The rel oncogene from the avian reticuloendotheliosis virus strain T is a 59 kd phosphoprotein localized primarily to the cytoplasm of transformed cells. Recently, the v-rel protein was shown to associate with several cellular proteins with molecular weights of 124 kd, 115 kd, and 36 kd. We have analysed the subcellul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Morrison LE,Kabrun N,Mudri S,Hayman MJ,Enrietto PJ

    更新日期:1989-06-01 00:00:00

  • Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells.

    abstract::Human T-cell leukemia virus type 1 (HTLV-1) Tax transforms normal T-cells in the presence of interleukin (IL)-2 in vitro. STAT is a family of transcription factors that play a pivotal role in cytokine-induced functions of a various type of cells. We investigated the involvement of STATs in the transformation of T-cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202608

    authors: Nakamura N,Fujii M,Tsukahara T,Arai M,Ohashi T,Wakao H,Kannagi M,Yamamoto N

    更新日期:1999-04-29 00:00:00

  • NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.

    abstract::The NF-kappa B precursor p100 (lyt-10, p97, p98) generates after proteolytic processing a 52 kDa subunit, which can bind to kappa B-motifs. A deregulated form of the p100 gene, which is structurally altered by a t(10;14) translocation, has a potential oncogenic role in certain human B cell lymphomas. In this study p10...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Naumann M,Nieters A,Hatada EN,Scheidereit C

    更新日期:1993-08-01 00:00:00

  • Role of the BLT2, a leukotriene B4 receptor, in Ras transformation.

    abstract::Oncogenic Ras is known to drive both the Rac and Raf-MAP-kinase pathways, which act in concert to cause cell transformation. Unlike the Raf-MAP-kinase cascade, however, the downstream elements of Rac pathway are not fully understood. Previously, we showed that cytosolic phospholipase A2 (cPLA2) and subsequent metaboli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208151

    authors: Yoo MH,Song H,Woo CH,Kim H,Kim JH

    更新日期:2004-12-09 00:00:00

  • Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.

    abstract::A new class of nontransformed revertant cells has been isolated from the ras-transformed cell line DT using cis-4-hydroxy-L-proline (CHP) as a selective agent. The new revertants, CHP 9CJ and CHP CB4, each contain two copies of the v-Ki-ras gene, elevated levels of phosphorylated p21ras protein, and rescuable transfor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yanagihara K,Ciardiello F,Talbot N,McGeady ML,Cooper H,Benade L,Salomon DS,Bassin RH

    更新日期:1990-08-01 00:00:00

  • Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human cancers, with 5-year patient survival rates of <5%. Activating mutations in KRAS are the predominant oncogenic drivers of PDAC but are accompanied by additional lower frequency genetic alterations. Our group previously identified the guanine ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0985-1

    authors: Joseph J,Radulovich N,Wang T,Raghavan V,Zhu CQ,Tsao MS

    更新日期:2020-01-01 00:00:00

  • Evidence for involvement of the protein kinase C pathway in the activation of p37v-mos protein kinase.

    abstract::Protein kinases are known to undergo phosphorylation to regulate their activity. To determine whether the protein kinase activity of p37v-mos was similarly regulated, we investigated the influence of two well known protein kinases, namely protein kinase C and protein kinase A, on the activity of p37v-mos in vivo. NIH3...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: al-Bagdadi F,Singh B,Arlinghaus RB

    更新日期:1990-08-01 00:00:00

  • Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

    abstract::Two thirds of breast cancers express estrogen receptors (ER). ER alpha (ERα) mediates breast cancer cell proliferation, and expression of ERα is the standard choice to indicate adjuvant endocrine therapy. ERbeta (ERβ) inhibits growth in vitro; its effects in vivo have been incompletely investigated and its role in bre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.261

    authors: Cotrim CZ,Fabris V,Doria ML,Lindberg K,Gustafsson JÅ,Amado F,Lanari C,Helguero LA

    更新日期:2013-05-09 00:00:00

  • Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells.

    abstract::Recent studies suggest that the action of platelet-activating factor (PAF), a potent phospholipid modulator of allergic and inflammatory reactions, is diverse and functions as a modulator of a variety of physiological and pathological events in many cell types and tissues. Its role (if any) in modulating the prolifera...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206348

    authors: Wang H,Chakrabarty S

    更新日期:2003-04-10 00:00:00

  • Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras.

    abstract::We have previously reported that platelet-derived growth factor (PDGF) induced tyrosine phosphorylation of GTPase-activating protein (GAP) in intact quiescent fibroblasts under conditions in which insulin and basic fibroblast growth factor (bFGF) were ineffective (Molloy et al., 1988). In the present study, we have pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Heidaran MA,Molloy CJ,Pangelinan M,Choudhury GG,Wang LM,Fleming TP,Sakaguchi AY,Pierce JH

    更新日期:1992-01-01 00:00:00

  • The role of BRCA1 in transcriptional regulation and cell cycle control.

    abstract::The exact functions of BRCA1 have not been fully described but it now seems apparent that it has roles in DNA damage repair, transcriptional regulation, cell cycle control and most recently in ubiquitylation. These functions of BRCA1 are most likely interdependent but this review will focus on the role of BRCA1 in rel...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209872

    authors: Mullan PB,Quinn JE,Harkin DP

    更新日期:2006-09-25 00:00:00

  • β-catenin S45F mutation results in apoptotic resistance.

    abstract::Wnt/β-catenin signaling is one of the key cascades regulating embryogenesis and tissue homeostasis; it has also been intimately associated with carcinogenesis. This pathway is deregulated in several tumors, including colorectal cancer, breast cancer, and desmoid tumors. It has been shown that CTNNB1 exon 3 mutations a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1382-5

    authors: Braggio D,Zewdu A,Londhe P,Yu P,Lopez G,Batte K,Koller D,Costas Casal de Faria F,Casadei L,Strohecker AM,Lev D,Pollock RE

    更新日期:2020-08-01 00:00:00

  • Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.

    abstract::Talins are adaptor proteins that regulate focal adhesion signaling by conjugating integrins to the cytoskeleton. Talins directly bind integrins and are essential for integrin activation. We previously showed that β1 integrins are activated in metastatic prostate cancer (PCa) cells, increasing PCa metastasis to lymph n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.116

    authors: Jin JK,Tien PC,Cheng CJ,Song JH,Huang C,Lin SH,Gallick GE

    更新日期:2015-04-02 00:00:00

  • Role of promoter methylation in regulation of the mammalian heparanase gene.

    abstract::Mammalian heparanase (endo-beta-glucuronidase) degrades heparan sulfate proteoglycans and is an important modulator of the extracellular matrix and associated factors. The enzyme is preferentially expressed in neoplastic tissues and contributes to tumour metastasis and angiogenesis. To investigate the epigenetic regul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207056

    authors: Shteper PJ,Zcharia E,Ashhab Y,Peretz T,Vlodavsky I,Ben-Yehuda D

    更新日期:2003-10-30 00:00:00

  • CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.

    abstract::CD44 is a cell surface receptor for hyaluronate, a component of the extracellular matrix (ECM). Although CD44 has been implicated in tumor invasion and metastasis, the molecular mechanisms remain to be elucidated. Here we find that CD44 expressed in cancer cells is cleaved at the membrane-proximal region of the ectodo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202447

    authors: Okamoto I,Kawano Y,Tsuiki H,Sasaki J,Nakao M,Matsumoto M,Suga M,Ando M,Nakajima M,Saya H

    更新日期:1999-02-18 00:00:00

  • The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.

    abstract::Tumor suppressor p53 forms a homo-tetramer through its COOH-terminal oligomerization domain and acts as a sequence-specific transcription factor. We have analysed the interrelation among the transcriptional activities, the structure and the cancer-related mutations in the oligomerization domain by using a comprehensiv...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208839

    authors: Kawaguchi T,Kato S,Otsuka K,Watanabe G,Kumabe T,Tominaga T,Yoshimoto T,Ishioka C

    更新日期:2005-10-20 00:00:00

  • Expression of nm23/NDP kinase proteins on the cell surface.

    abstract::We determined whether proteins encoded by the nm23/nucleoside diphosphate (NDP) kinase gene, a potential metastasis-suppressor gene, are expressed on the cell surface. Monoclonal antibodies (mAb) specific for nm23-H1 or H2 proteins were prepared using the corresponding fusion proteins with glutathione S-transferase (G...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Urano T,Furukawa K,Shiku H

    更新日期:1993-05-01 00:00:00

  • Mysterious liaisons: the relationship between c-Myc and the cell cycle.

    abstract::A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202749

    authors: Obaya AJ,Mateyak MK,Sedivy JM

    更新日期:1999-05-13 00:00:00